molecular classification
Showing 1 - 25 of 7,731
Staging Endometrial caNcer Based on molEcular ClAssification
Recruiting
- Endometrial Cancer
- +2 more
-
Pamplona, Navarra, SpainClinica Universidad de Navarra
Jan 30, 2023
Concordance of Molecular Classification Based on Fine Needle
Not yet recruiting
- Papillary Thyroid Cancer
-
Calgary, Alberta, CanadaFoothills Medical Centre
Nov 17, 2023
MRI Radiomics Combined With Pathomics on Prediction of Molecular
Not yet recruiting
- Endometrial Neoplasms
- next generation sequencing AND Immunohistochemical examination
-
Fuzhou, Fujian, ChinaClinical Oncology School of Fujian Medical University, Fujian Ca
Nov 13, 2023
Molecular Classification of Relapsed/Refractory Diffuse Large
Completed
- Lymphoma, Large B-Cell, Diffuse
- Gene Expression Profiling
- Gene expression profile
-
Shanghai, Shanghai, ChinaYian Zhang
Mar 31, 2022
HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)
Not yet recruiting
- HR+/HER2-breast Cancer
- Standard endocrine therapy plus Apatinib
- (no location specified)
Jun 2, 2023
Early Diagnosis of Digestive System Cancers
Recruiting
- Esophageal Cancer
- +3 more
-
Shanghai, Shanghai, China
- +3 more
Jun 19, 2022
Based on Molecular Typing of Medulloblastoma in Children
Not yet recruiting
- Medulloblastoma, Childhood
- Prospective observational study, no intervention
- (no location specified)
Jun 4, 2022
Pancreatic Cancer Molecular Sub-classification Using Endoscopic
Active, not recruiting
- Pancreas Cancer
-
Rome, ItalyUniversita' Cattolica del Sacro Cuore
Feb 10, 2022
ABO Blood Type Incompatible Kidney Transplantation, Antibody-mediated Rejection Trial in Seoul (5-gene classification model)
Active, not recruiting
- ABO Blood Type Incompatible Kidney Transplantation
- Antibody-mediated Rejection
- 5-gene classification model
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 24, 2022
Metastatic Renal Cell Carcinoma Trial in Shanghai (sunitinib or pazopanib, PD-1 inhibitor combined with axitinib)
Recruiting
- Metastatic Renal Cell Carcinoma
- sunitinib or pazopanib
- PD-1 inhibitor combined with axitinib
-
Shanghai, Shanghai, ChinaRenji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Apr 16, 2023
Molecular Imaging Trial in Harbin (18F-IRS)
Completed
- Molecular Imaging
- 18F-IRS
-
Harbin, Heilongjiang, ChinaTOF-PET/CT/MR center of the Fourth Hospital of Harbin Medical Un
Feb 20, 2020
Corresponding to Different Molecular Subtypes of Brest Cancer. A
Completed
- Breast Cancer
- (no location specified)
Feb 24, 2023
Endometrial Cancer Trial in Vancouver (Treatment de-escalation)
Recruiting
- Endometrial Cancer
- Treatment de-escalation
-
Vancouver, British Columbia, CanadaBC Cancer - Vancouver Centre
Mar 1, 2022
Circulating Tumor DNA in Surgical Patients With Lung Cancer
Active, not recruiting
- Lung Cancer
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 12, 2022
Endometrial Adenocarcinoma Trial in Helsinki (Comparison of adjuvant therapies)
Recruiting
- Endometrial Adenocarcinoma
- Comparison of adjuvant therapies
-
Helsinki, FinlandHelsinki University Hospital
Dec 8, 2022
Ischemic Heart Disease ( BIOMS-IHD )
Recruiting
- Cardiovascular Diseases
-
Beijing, Beijing, ChinaBeijing Anzhen Hospital
Jul 20, 2023
Shear-wave Elastography in Breast Cancer
Not yet recruiting
- Breast Cancer
- elastography
- (no location specified)
Nov 3, 2023
Molecular Imaging Trial in Harbin (18F-MPG)
Unknown status
- Molecular Imaging
- 18F-MPG
-
Harbin, Heilongjiang, ChinaTOF-PET/CT/MR center of the Fourth Hospital of Harbin Medical Un
Jun 23, 2019
Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)
Not yet recruiting
- Endometrial Cancer
- Vaginal brachytherapy
- +2 more
- (no location specified)
Nov 29, 2022
Clinical, Radiological, Histologic and Molecular Features
Recruiting
- Meningeal Melanocytoma
- +3 more
-
Nancy, FranceNancy University Hospital Center
Jul 31, 2023
Glioma (Diagnosis), Liquid Biopsy, Deep Learning Trial in Wuhan, Nanchang (Prediction of glioma grading and molecular subtype)
Recruiting
- Glioma (Diagnosis)
- +2 more
- Prediction of glioma grading and molecular subtype
-
Wuhan, Hubei, China
- +1 more
Sep 8, 2022
Endometrial Cancer Trial (Letrozole 2.5mg)
Not yet recruiting
- Endometrial Cancer
- Letrozole 2.5mg
- (no location specified)
Jul 26, 2022
MRI-based Computer Aided Diagnosis Software (V1) for Glioma
Enrolling by invitation
- Glioma
- Primary Brain Tumor
-
Shanghai, Shanghai, ChinaZhen Fan
Feb 11, 2023
Breast Microcalcifications' Classification With Artificial
Recruiting
- Breast Cancer
- Microcalcification
-
Pavia, Lombardia, ItalyIstituti Clinici Scientifici Maugeri SpA
Mar 2, 2023
PaCIFiC-CUP Classifies Cancer of Unknown Primary
Recruiting
- Unknown Primary Tumors
- DNA Methylation
-
Guangzhou, Guangdong, ChinaSun Yat-sen university cancer center
Nov 20, 2023